This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Plaintiff's burden of proof for 'other concerted acts' clarified by China's Supreme Court

By MLex Staff ( October 11, 2022, 05:59 GMT | Insight) -- China’s top court has clarified the plaintiff’s burden of proof in a cartel case involving drinking water when determining “other concerted acts” that are prohibited in the antitrust law involving monopoly agreements. In the second-instance trial ruling, the top court dismissed the case and noted the plaintiff needed to provide preliminary evidence of three factors when arguing for “concerted acts.” Those factors are whether businesses’ market behavior is consistent; whether they communicated or exchanged information; and other circumstances including market structure, competition status and changes in the relevant markets.China’s top court has clarified the plaintiff’s burden of proof in a cartel case involving drinking water when determining “other concerted acts” that are prohibited in the antitrust law involving monopoly agreements....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections